Treatment Approaches for R/R Follicular Lymphoma in the 3L and Beyond

Opinion
Video

An expert discussion surrounding the evolving treatment landscape for relapsed or refractory follicular lymphoma in the third-line setting and beyond.

Recent Videos
Jose Sandoval Sus, MD, discussed standard CAR T-cell therapies in patients across multiple high-risk lymphoma indications.
4 experts in this video
4 experts in this video
Barriers to access and financial toxicities are challenges that must be addressed for CAR T-cell therapies in LBCL, according to Jose Sandoval Sus, MD.
4 experts in this video
4 experts in this video
4 experts in this video
4 experts in this video
Related Content